stockrowNanobiotix S.A. - Sponsored ADR
NBTXNanobiotix S.A. - Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $36.9 million.
Follow NBTX
Alert me
Nanobiotix S.A. - Sponsored ADR (NBTX) Return on invested capital
Nanobiotix S.A. - Sponsored ADR's return on invested capital over the twelve months to 30 June 2026 was 0.00%, down 0.0 percentage points from fiscal 2025 (0.00%). Over the past ten years it has ranged from 0.00% (fiscal 2025) to 0.00% (fiscal 2025) — the current reading is the highest in ten years. That is in line with the Biotechnology industry median of 0.00% and in line with the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 0.00% | 0.00 |
| FY2024 | 0.00% | 0.00 |
| FY2023 | 0.00% | 0.00 |
| FY2022 | 0.00% | 0.00 |
| FY2021 | 0.00% | 0.00 |
| FY2020 | 0.00% | 0.00 |
| FY2019 | 0.00% | 0.00 |
| FY2018 | 0.00% | 0.00 |
| FY2017 | 0.00% | 0.00 |
| FY2016 | 0.00% | — |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| PGEN Precigen, Inc. compare | 15.9% |
| RAPP Rapport Therapeutics, Inc. compare | 0.00% |
| RARE Ultragenyx Pharmaceutical Inc. compare | 0.00% |
| SLS SELLAS Life Sciences Group, Inc. compare | 0.00% |
| QURE uniQure N.V. compare | 0.00% |
| IMCR Immunocore Holdings PLC Sponsored ADR compare | 0.00% |
| NUVB Nuvation Bio Inc. compare | 0.00% |
| NBTX Nanobiotix S.A. - Sponsored ADR | 0.00% |
| NTLA Intellia Therapeutics, Inc. compare | −195.3% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)